CLINICAL ASPECTS OF TREATMENT OF PATIENTS WITH LONG-PERSISTENT FORMOF ATRIAL FIBRILLATION AND DECOMPENSATED CHRONIC HEART FAILURE, USING A METHODOF RADIOFREQUENCY CATHETER ABLATION AND CARDIAC RESYNCHRONIZATION THERAPY

A A Kocharyan; E G Zhelyakov; R R Guseynova; A V Konev; A V Ardashev

doi:10.17816/clinpract4349-55

Journal of Clinical Practice ›› 2013, Vol. 4 ›› Issue (3) : 49 -55. DOI: 10.17816/clinpract4349-55

Articles

research-article

CLINICAL ASPECTS OF TREATMENT OF PATIENTS WITH LONG-PERSISTENT FORMOF ATRIAL FIBRILLATION AND DECOMPENSATED CHRONIC HEART FAILURE, USING A METHODOF RADIOFREQUENCY CATHETER ABLATION AND CARDIAC RESYNCHRONIZATION THERAPY

Author information +

History +

PDF

Abstract

The article describes a clinical case of a 64-years patient with long-lasting persistent atrial fibrillation with the progressive course of chronic heart failure, which successfully treated with CRT setting and RFA of AFib. Dynamic observation of the patient during 12 months confirmed the success of combined treatment – absence of arrhythmia recurrences and decreasing of NYHA heart failure functional class.

Keywords

long-lasting persistent atrial fibrillation / radiofrequency catheter ablation / chronic heart failure

Cite this article

Download citation ▾

A A Kocharyan, E G Zhelyakov, R R Guseynova, A V Konev, A V Ardashev. CLINICAL ASPECTS OF TREATMENT OF PATIENTS WITH LONG-PERSISTENT FORMOF ATRIAL FIBRILLATION AND DECOMPENSATED CHRONIC HEART FAILURE, USING A METHODOF RADIOFREQUENCY CATHETER ABLATION AND CARDIAC RESYNCHRONIZATION THERAPY. Journal of Clinical Practice, 2013, 4(3): 49-55 DOI:10.17816/clinpract4349-55

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Heeringa J., van der Kuip D.A., Hofman A. et.al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur heart J 2006; 27: 949-953.

[2]	Stewart S., Hart C.L., Hole D.J., McMurray J.J. A population-based study of the long-term risks associated with the atrial fibrillation: 20-year follow-up of the Renfrew. Paisley study. Am J Med 2002; 113: 359-364.

[3]	Lloyd-Jones D.M., Wang T.J., Leip E.P. et al. Lifetime risk for development of atrial fibrillation: Framingham Heart Study. Circulation 2004; 110: 1042-46.

[4]	Friberg J., Buch P., Scharling H., Gadsbphioll N., Jensen G.B. Rising rates of hospital admissions for atrial. fibrillation. Epidemiology 2003; 14 (6): 666-72.

[5]	Lloyd-Jones DM, Wang TJ, Leip EP, et al. (August 2004). Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110 (9): 1042-6.

[6]	European society of cardiology. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. 2012.

[7]	European society of cardiology. 2012 HRS/ EHRA/ ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, end-points, and research trial design. 2012.